Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Newbouldia laevis leaf extract is a botanical preparation derived from the leaves of the Newbouldia laevis tree, a species native to tropical Africa and commonly known as the African border tree. In traditional Nigerian medicine, the extract is utilized for its purported analgesic, anti-inflammatory, and anticonvulsant properties, particularly in the management of pain, inflammatory conditions, convulsions, and epilepsy. Scientific studies in animal models, such as Wistar rats, have provided evidence supporting these ethnomedicinal claims, demonstrating significant activity in reducing pain perception and seizure frequency. The pharmacological effects are attributed to a complex mixture of phytochemicals, including flavonoids, alkaloids, tannins, and saponins, which are thought to modulate inflammatory pathways and neurotransmitter systems in the central nervous system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on newbouldia laevis leaf extract.